Xmark continues to invest in Genaera

By Lisa Kerner

Charlotte, N.C., Sept. 7 - Xmark Opportunity Partners, LLC added to its stake in Genaera Corp. with the purchase of 212,500 shares of the company's stock between Aug. 9 and Aug. 28 priced from $2.79 to $3.06 each.

The transactions were listed in a schedule 13D filing with the Securities and Exchange Commission.

Xmark owns 3,571,542 shares, or 20.5%, of the Plymouth Meeting, Pa., biopharmaceutical company.

On Aug. 17, Xmark reported buying 212,500 shares between July 27 and Aug. 8 priced from $2.67 to $3.00 each, for a 19.4% stake in Genaera, according to a previous SEC filing. Xmark owned 18.2% of the company's outstanding shares on Aug. 6.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.